Drug Shortage Report for MULTI 12 INJECTION

Last updated on 2023-03-06 History
Report ID 168548
Drug Identification Number 02100606
Brand name MULTI 12 INJECTION
Common or Proper name MULTI-12
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) VITAMIN B12 FOLIC ACID BIOTIN VITAMIN E DEXPANTHENOL PYRIDOXINE HYDROCHLORIDE NICOTINAMIDE VITAMIN B2 VITAMIN B1 VITAMIN D VITAMIN A ASCORBIC ACID
Strength(s) 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5ML
ATC code B05XC
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-12
Estimated end date 2023-02-17
Actual end date 2023-03-03
Shortage status Resolved
Updated date 2023-03-06
Company comments Baxter item : 6410 Product is available on allocation based on 50% of historical volumes
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2023-03-06 French Compare
v25 2023-03-06 English Compare
v24 2023-02-14 French Compare
v23 2023-02-14 English Compare
v22 2022-12-16 French Compare
v21 2022-12-16 English Compare
v20 2022-12-16 French Compare
v19 2022-12-16 English Compare
v18 2022-12-16 French Compare
v17 2022-12-16 English Compare
v16 2022-12-15 French Compare
v15 2022-12-15 English Compare
v14 2022-12-15 French Compare
v13 2022-12-15 English Compare
v12 2022-12-13 English Compare
v11 2022-12-12 French Compare
v10 2022-12-12 English Compare
v9 2022-11-29 French Compare
v8 2022-11-29 English Compare
v7 2022-11-29 French Compare

Showing 1 to 20 of 26